Approved for 1 INDICATIONS AND USAGE ILEVRO ® 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery. ILEVRO ® 0.3% is a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 ).. 12.1 Mechanism of Action After topical ocular dosing, nepafenac penetrates the cornea and is converted…
Loading full data from Know Your Drugs Institute…